http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-337399-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_269dc5c69a5c945148f54aefcb35dc20
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 1998-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97b902ca4820c5cd25376cc5e93e2f91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d32f028fb7a574c2e452f02b65af389a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11af8cb33bdc3b3e2394ee3cc8abc793
publicationDate 2000-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-337399-A
titleOfInvention O-sulfated K4, K5 and K40 bacterial polysaccharides
abstract rocess for the preparation of O-sulfated K4, K5 and K40 polysaccharides useful for the treatment of tumoral, HIV-1 and coagulation pathologies and in cosmetic preparations, wherein the K4, K5 or K40 polysaccharide in the form of sodium salt is suspended in an aprotic solvent and directly submitted to the reaction of O-sulfation with a pyridine-sulphur trioxide or trimethylamine-sulphur trioxide adduct or with chlorosulfonic acid. Also included is the use of said O-sulfated polysaccharides in the treatment of tumoral, HIV-1 and coagulation pathologies, cosmetic compositions and in the prevention of hair loss.
priorityDate 1997-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452983531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448629235

Total number of triples: 38.